Glassman Wealth Services’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Glassman Wealth Services’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20	Closed	-$2K	–	2101
2022 Q2	$2K	Buy	+20	New	+$889	﹤0.01%	1321
2022 Q1	–	Sell	-21	Closed	-$1K	–	2056
2021 Q4	$1K	Buy	+21	New	+$939	﹤0.01%	1590

Glassman Wealth Services's TPTX Position: Q3 2022 in Review

Glassman Wealth Services sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 20 shares — an estimated $2K sold.

Glassman Wealth Services first reported a position in TPTX in Q4 2021 and held it in 2 quarters. The position peaked at $2K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Glassman Wealth Services reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Glassman Wealth Services sold 20 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2K.
Glassman Wealth Services first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
Glassman Wealth Services's Turning Point Therapeutics, Inc. Common Stock position peaked at $2K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Glassman Wealth Services's 13F filing for Q3 2022, filed 9 Nov 2022.